1 Antiepileptic Drugs Market Overview 1.1 Antiepileptic Drugs Product Scope 1.2 Antiepileptic Drugs Segment by Type 1.2.1 Global Antiepileptic Drugs Sales by Type (2020-2026) 1.2.2 First generation 1.2.3 Second generation 1.3 Antiepileptic Drugs Segment by Application 1.3.1 Global Antiepileptic Drugs Sales Comparison by Application (2020-2026) 1.3.2 Hosptial 1.3.3 Clinic 1.3.4 Research 1.4 Antiepileptic Drugs Market Estimates and Forecasts (2015-2026) 1.4.1 Global Antiepileptic Drugs Sales Growth Rate (2015-2026) 1.4.2 Global Antiepileptic Drugs Revenue and Growth Rate (2015-2026) 1.4.3 Global Antiepileptic Drugs Price Trends (2015-2026) 2 Antiepileptic Drugs Estimate and Forecast by Region 2.1 Global Antiepileptic Drugs Market Size by Region: 2015 VS 2020 VS 2026 2.2 Global Antiepileptic Drugs Retrospective Market Scenario by Region (2015-2020) 2.2.1 Global Antiepileptic Drugs Sales Market Share by Region (2015-2020) 2.2.2 Global Antiepileptic Drugs Revenue Market Share by Region (2015-2020) 2.3 Global Antiepileptic Drugs Market Estimates and Forecasts by Region (2021-2026) 2.3.1 Global Antiepileptic Drugs Sales Estimates and Forecasts by Region (2021-2026) 2.3.2 Global Antiepileptic Drugs Revenue Forecast by Region (2021-2026) 2.4 Geographic Market Analysis: Market Facts & Figures 2.4.1 United States Antiepileptic Drugs Estimates and Projections (2015-2026) 2.4.2 Europe Antiepileptic Drugs Estimates and Projections (2015-2026) 2.4.3 China Antiepileptic Drugs Estimates and Projections (2015-2026) 2.4.4 Japan Antiepileptic Drugs Estimates and Projections (2015-2026) 2.4.5 Southeast Asia Antiepileptic Drugs Estimates and Projections (2015-2026) 2.4.6 India Antiepileptic Drugs Estimates and Projections (2015-2026) 3 Global Antiepileptic Drugs Competition Landscape by Players 3.1 Global Top Antiepileptic Drugs Players by Sales (2015-2020) 3.2 Global Top Antiepileptic Drugs Players by Revenue (2015-2020) 3.3 Global Antiepileptic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiepileptic Drugs as of 2019) 3.4 Global Antiepileptic Drugs Average Price by Company (2015-2020) 3.5 Manufacturers Antiepileptic Drugs Manufacturing Sites, Area Served, Product Type 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3.7 Primary Interviews with Key Antiepileptic Drugs Players (Opinion Leaders) 4 Global Antiepileptic Drugs Market Size by Type 4.1 Global Antiepileptic Drugs Historic Market Review by Type (2015-2020) 4.1.1 Global Antiepileptic Drugs Sales Market Share by Type (2015-2020) 4.1.2 Global Antiepileptic Drugs Revenue Market Share by Type (2015-2020) 4.1.3 Global Antiepileptic Drugs Price by Type (2015-2020) 4.2 Global Antiepileptic Drugs Market Estimates and Forecasts by Type (2021-2026) 4.2.1 Global Antiepileptic Drugs Sales Forecast by Type (2021-2026) 4.2.2 Global Antiepileptic Drugs Revenue Forecast by Type (2021-2026) 4.2.3 Global Antiepileptic Drugs Price Forecast by Type (2021-2026) 5 Global Antiepileptic Drugs Market Size by Application 5.1 Global Antiepileptic Drugs Historic Market Review by Application (2015-2020) 5.1.1 Global Antiepileptic Drugs Sales Market Share by Application (2015-2020) 5.1.2 Global Antiepileptic Drugs Revenue Market Share by Application (2015-2020) 5.1.3 Global Antiepileptic Drugs Price by Application (2015-2020) 5.2 Global Antiepileptic Drugs Market Estimates and Forecasts by Application (2021-2026) 5.2.1 Global Antiepileptic Drugs Sales Forecast by Application (2021-2026) 5.2.2 Global Antiepileptic Drugs Revenue Forecast by Application (2021-2026) 5.2.3 Global Antiepileptic Drugs Price Forecast by Application (2021-2026) 6 United States Antiepileptic Drugs Market Facts & Figures 6.1 United States Antiepileptic Drugs Sales Market Share by Company (2015-2020) 6.2 United States Antiepileptic Drugs Sales Market Share by Type (2015-2020) 6.3 United States Antiepileptic Drugs Sales Market Share by Application (2015-2020) 7 Europe Antiepileptic Drugs Market Facts & Figures 7.1 Europe Antiepileptic Drugs Sales Market Share by Company (2015-2020) 7.2 Europe Antiepileptic Drugs Sales Market Share by Type (2015-2020) 7.3 Europe Antiepileptic Drugs Sales Market Share by Application (2015-2020) 8 China Antiepileptic Drugs Market Facts & Figures 8.1 China Antiepileptic Drugs Sales Market Share by Company (2015-2020) 8.2 China Antiepileptic Drugs Sales Market Share by Type (2015-2020) 8.3 China Antiepileptic Drugs Sales Market Share by Application (2015-2020) 9 Japan Antiepileptic Drugs Market Facts & Figures 9.1 Japan Antiepileptic Drugs Sales Market Share by Company (3015-3030) 9.2 Japan Antiepileptic Drugs Sales Market Share by Type (2015-2020) 9.3 Japan Antiepileptic Drugs Sales Market Share by Application (2015-2020) 10 Southeast Asia Antiepileptic Drugs Market Facts & Figures 10.1 Southeast Asia Antiepileptic Drugs Sales Market Share by Company (2015-2020) 10.2 Southeast Asia Antiepileptic Drugs Sales Market Share by Type (2015-2020) 10.3 Southeast Asia Antiepileptic Drugs Sales Market Share by Application (2015-2020) 11 India Antiepileptic Drugs Market Facts & Figures 11.1 India Antiepileptic Drugs Sales Market Share by Company (2015-2020) 11.2 India Antiepileptic Drugs Sales Market Share by Type (2015-2020) 11.3 India Antiepileptic Drugs Sales Market Share by Application (2015-2020) 12 Company Profiles and Key Figures in Antiepileptic Drugs Business 12.1 GlaxoSmithKline 12.1.1 GlaxoSmithKline Corporation Information 12.1.2 GlaxoSmithKline Business Overview 12.1.3 GlaxoSmithKline Antiepileptic Drugs Sales, Revenue and Gross Margin (2015-2020) 12.1.4 GlaxoSmithKline Antiepileptic Drugs Products Offered 12.1.5 GlaxoSmithKline Recent Development 12.2 Johnson & Johnson 12.2.1 Johnson & Johnson Corporation Information 12.2.2 Johnson & Johnson Business Overview 12.2.3 Johnson & Johnson Antiepileptic Drugs Sales, Revenue and Gross Margin (2015-2020) 12.2.4 Johnson & Johnson Antiepileptic Drugs Products Offered 12.2.5 Johnson & Johnson Recent Development 12.3 Sanofi 12.3.1 Sanofi Corporation Information 12.3.2 Sanofi Business Overview 12.3.3 Sanofi Antiepileptic Drugs Sales, Revenue and Gross Margin (2015-2020) 12.3.4 Sanofi Antiepileptic Drugs Products Offered 12.3.5 Sanofi Recent Development 12.4 Pfizer 12.4.1 Pfizer Corporation Information 12.4.2 Pfizer Business Overview 12.4.3 Pfizer Antiepileptic Drugs Sales, Revenue and Gross Margin (2015-2020) 12.4.4 Pfizer Antiepileptic Drugs Products Offered 12.4.5 Pfizer Recent Development 12.5 Novartis 12.5.1 Novartis Corporation Information 12.5.2 Novartis Business Overview 12.5.3 Novartis Antiepileptic Drugs Sales, Revenue and Gross Margin (2015-2020) 12.5.4 Novartis Antiepileptic Drugs Products Offered 12.5.5 Novartis Recent Development 12.6 Abbott 12.6.1 Abbott Corporation Information 12.6.2 Abbott Business Overview 12.6.3 Abbott Antiepileptic Drugs Sales, Revenue and Gross Margin (2015-2020) 12.6.4 Abbott Antiepileptic Drugs Products Offered 12.6.5 Abbott Recent Development 12.7 Sunovion 12.7.1 Sunovion Corporation Information 12.7.2 Sunovion Business Overview 12.7.3 Sunovion Antiepileptic Drugs Sales, Revenue and Gross Margin (2015-2020) 12.7.4 Sunovion Antiepileptic Drugs Products Offered 12.7.5 Sunovion Recent Development 12.8 Cephalon (Teva) 12.8.1 Cephalon (Teva) Corporation Information 12.8.2 Cephalon (Teva) Business Overview 12.8.3 Cephalon (Teva) Antiepileptic Drugs Sales, Revenue and Gross Margin (2015-2020) 12.8.4 Cephalon (Teva) Antiepileptic Drugs Products Offered 12.8.5 Cephalon (Teva) Recent Development 13 Antiepileptic Drugs Manufacturing Cost Analysis 13.1 Antiepileptic Drugs Key Raw Materials Analysis 13.1.1 Key Raw Materials 13.1.2 Key Raw Materials Price Trend 13.1.3 Key Suppliers of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.3 Manufacturing Process Analysis of Antiepileptic Drugs 13.4 Antiepileptic Drugs Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers 14.1 Marketing Channel 14.2 Antiepileptic Drugs Distributors List 14.3 Antiepileptic Drugs Customers 15 Market Dynamics 15.1 Antiepileptic Drugs Market Trends 15.2 Antiepileptic Drugs Opportunities and Drivers 15.3 Antiepileptic Drugs Market Challenges 15.4 Antiepileptic Drugs Market Restraints 15.5 Porter's Five Forces Analysis 16 Research Findings and Conclusion 17 Appendix 17.1 Research Methodology 17.1.1 Methodology/Research Approach 17.1.2 Data Source 17.2 Author List 17.3 Disclaimer

List of Tables Table 1. Global Antiepileptic Drugs Sales (MT) Growth Rate by Type (2020-2026) (US$ Million) Table 2. Global Antiepileptic Drugs Sales (MT) Comparison by Application (2020-2026) (US$ Million) Table 3. Global Market Antiepileptic Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026 Table 4. Global Antiepileptic Drugs Sales (MT) by Region (2015-2020) Table 5. Global Antiepileptic Drugs Sales Market Share by Region (2015-2020) Table 6. Global Antiepileptic Drugs Revenue (US$ Million) Market Share by Region (2015-2020)) Table 7. Global Antiepileptic Drugs Revenue Share by Region (2015-2020) Table 8. Global Antiepileptic Drugs Sales (MT) Forecast by Region (2021-2026) Table 9. Global Antiepileptic Drugs Sales Market Share Forecast by Region (2021-2026) Table 10. Global Antiepileptic Drugs Revenue (US$ Million) Forecast by Region (2021-2026) Table 11. Global Antiepileptic Drugs Revenue Share Forecast by Region (2021-2026) Table 12. Global Antiepileptic Drugs (MT) of Key Companies (2015-2020) Table 13. Global Antiepileptic Drugs Sales Share by Company (2015-2020) Table 14. Global Antiepileptic Drugs Revenue (US$ Million) by Company (2015-2020) Table 15. Global Antiepileptic Drugs Revenue Share by Company (2015-2020) Table 16. Global Antiepileptic Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiepileptic Drugs as of 2019) Table 17. Global Antiepileptic Drugs Average Price (USD/Kg) of Key Company (2015-2020) Table 18. Manufacturers Antiepileptic Drugs Manufacturing Sites and Area Served Table 19. Manufacturers Antiepileptic Drugs Product Type Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans Table 21. Main Points Interviewed from Key Antiepileptic Drugs Players Table 22. Global Antiepileptic Drugs Sales (MT) by Type (2015-2020) Table 23. Global Antiepileptic Drugs Sales Share by Type (2015-2020) Table 24. Global Antiepileptic Drugs Revenue (US$ Million) Market Share by Type (2015-2020) Table 25. Global Antiepileptic Drugs Price (MT) by Type (2015-2020) Table 26. Global Antiepileptic Drugs Sales Share by Type (2021-2026) Table 27. Global Antiepileptic Drugs Revenue (US$ Million) Market Share by Type (2021-2026) Table 28. Global Antiepileptic Drugs Revenue Share by Type (2021-2026) Table 29. Global Antiepileptic Drugs Price (MT) by Type (2021-2026) Table 30. Global Antiepileptic Drugs Sales (MT) by Application (2015-2020) Table 31. Global Antiepileptic Drugs Sales Share by Application (2015-2020) Table 32. Global Antiepileptic Drugs Revenue (US$ Million) Market Share by Application (2015-2020) Table 33. Global Antiepileptic Drugs Price (MT) by Application (2015-2020) Table 34. Global Antiepileptic Drugs Sales (MT) by Application (2021-2026) Table 35. Global Antiepileptic Drugs Sales Share by Application (2021-2026) Table 36. Global Antiepileptic Drugs Revenue (US$ Million) Market Share by Application (2021-2026) Table 37. Global Antiepileptic Drugs Revenue Share by Application (2021-2026) Table 38. Global Antiepileptic Drugs Price (MT) by Application (2021-2026) Table 39. United States Antiepileptic Drugs Sales (MT) by Company (2015-2020) Table 40. United States Antiepileptic Drugs Sales Market Share by Company (2015-2020) Table 41. United States Antiepileptic Drugs Sales (MT) by Type (2015-2020) Table 42. United States Antiepileptic Drugs Sales Market Share by Type (2015-2020) Table 43. United States Antiepileptic Drugs Sales (MT) by Application (2015-2020) Table 44. United States Antiepileptic Drugs Sales Market Share by Application (2015-2020) Table 45. Europe Antiepileptic Drugs Sales (MT) by Company (2015-2020) Table 46. Europe Antiepileptic Drugs Sales Market Share by Company (2015-2020) Table 47. Europe Antiepileptic Drugs Sales (MT) by Type (2015-2020) Table 48. Europe Antiepileptic Drugs Sales Market Share by Type (2015-2020) Table 49. Europe Antiepileptic Drugs Sales (MT) by Application (2015-2020) Table 50. Europe Antiepileptic Drugs Sales Market Share by Type (2015-2020) Table 51. China Antiepileptic Drugs Sales (MT) by Company (2015-2020) Table 52. China Antiepileptic Drugs Sales Market Share by Company (2015-2020) Table 53. China Antiepileptic Drugs Sales (MT) by Type (2015-2020) Table 54. China Antiepileptic Drugs Sales Market Share by Type (2015-2020) Table 55. China Antiepileptic Drugs Sales (MT) by Application (2015-2020) Table 56. China Antiepileptic Drugs Sales Market Share by Application (2015-2020) Table 57. Japan Antiepileptic Drugs Sales (MT) by Company (2015-2020) Table 58. Japan Antiepileptic Drugs Sales Market Share by Company (2015-2020) Table 59. Japan Antiepileptic Drugs Sales (MT) by Type (2015-2020) Table 60. Japan Antiepileptic Drugs Sales Market Share by Type (2015-2020) Table 61. Japan Antiepileptic Drugs Sales (MT) by Application (2015-2020) Table 62. Japan Antiepileptic Drugs Sales Market Share by Application (2015-2020) Table 63. Southeast Asia Antiepileptic Drugs Sales (MT) by Company (2015-2020) Table 64. Southeast Asia Antiepileptic Drugs Sales Market Share by Company (2015-2020) Table 65. Southeast Asia Antiepileptic Drugs Sales (MT) by Type (2015-2020) Table 66. Southeast Asia Antiepileptic Drugs Sales Market Share by Type (2015-2020) Table 67. Southeast Asia Antiepileptic Drugs Sales (MT) by Type (2015-2020) Table 68. Southeast Asia Antiepileptic Drugs Sales Market Share by Application (2015-2020) Table 69. India Antiepileptic Drugs Sales (MT) by Company (2015-2020) Table 70. India Antiepileptic Drugs Sales Market Share by Company (2015-2020) Table 71. India Antiepileptic Drugs Sales (MT) by Type (2015-2020) Table 72. India Antiepileptic Drugs Sales Market Share by Type (2015-2020) Table 73. India Antiepileptic Drugs Sales (MT) by Application (2015-2020) Table 74. India Antiepileptic Drugs Sales Market Share by Application (2015-2020) Table 75. GlaxoSmithKline Corporation Information Table 76. GlaxoSmithKline Description and Business Overview Table 77. GlaxoSmithKline Antiepileptic Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020) Table 78. GlaxoSmithKline Antiepileptic Drugs Product Table 79. GlaxoSmithKline Recent Development Table 80. Johnson & Johnson Corporation Information Table 81. Johnson & Johnson Description and Business Overview Table 82. Johnson & Johnson Antiepileptic Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020) Table 83. Johnson & Johnson Antiepileptic Drugs Product Table 84. Johnson & Johnson Recent Development Table 85. Sanofi Corporation Information Table 86. Sanofi Description and Business Overview Table 87. Sanofi Antiepileptic Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020) Table 88. Sanofi Antiepileptic Drugs Product Table 89. Sanofi Recent Development Table 90. Pfizer Corporation Information Table 91. Pfizer Description and Business Overview Table 92. Pfizer Antiepileptic Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020) Table 93. Pfizer Antiepileptic Drugs Product Table 94. Pfizer Recent Development Table 95. Novartis Corporation Information Table 96. Novartis Description and Business Overview Table 97. Novartis Antiepileptic Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020) Table 98. Novartis Antiepileptic Drugs Product Table 99. Novartis Recent Development Table 100. Abbott Corporation Information Table 101. Abbott Description and Business Overview Table 102. Abbott Antiepileptic Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020) Table 103. Abbott Antiepileptic Drugs Product Table 104. Abbott Recent Development Table 105. Sunovion Corporation Information Table 106. Sunovion Description and Business Overview Table 107. Sunovion Antiepileptic Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020) Table 108. Sunovion Antiepileptic Drugs Product Table 109. Sunovion Recent Development Table 110. Cephalon (Teva) Corporation Information Table 111. Cephalon (Teva) Antiepileptic Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020) Table 112. Cephalon (Teva) Description and Business Overview Table 113. Cephalon (Teva) Antiepileptic Drugs Product Table 114. Cephalon (Teva) Recent Development Table 115. Production Base and Market Concentration Rate of Raw Material Table 116. Key Suppliers of Raw Materials Table 117. Antiepileptic Drugs Distributors List Table 118. Antiepileptic Drugs Customers List Table 119. Antiepileptic Drugs Market Key Trends Table 120. Antiepileptic Drugs Key Opportunities and Drivers Table 121. Antiepileptic Drugs Market Challenges Table 122. Research Programs/Design for This Report Table 123. Key Data Information from Secondary Sources Table 124. Key Data Information from Primary Sources List of Figures Figure 1. Antiepileptic Drugs Product Picture Figure 2. Global Antiepileptic Drugs Sales Market Share by Type in 2020 & 2026 Figure 3. Type I Product Picture Figure 4. Type II Product Picture Figure 5. Global Antiepileptic Drugs Market Share by Application in 2020 & 2026 Figure 6. Hosptial Examples Figure 7. Clinic Examples Figure 8. Research Examples Figure 9. Global Antiepileptic Drugs Sales (MT) Growth Rate (2015-2026) Figure 10. Global Antiepileptic Drugs Revenue (US$ Million) Growth Rate (2015-2026) Figure 11. Global Antiepileptic Drugs Price Trends Growth Rate (2015-2026) (USD/Kg) Figure 12. Global Antiepileptic Drugs Revenue Market Share by Region: 2015 VS 2020 Figure 13. Global Antiepileptic Drugs Revenue Market Share by Region: 2021 VS 2026 Figure 14. United States Antiepileptic Drugs Revenue (Million USD) Growth Rate (2015-2026) Figure 15. United States Antiepileptic Drugs Sales (MT) Growth Rate (2015-2026) Figure 16. Europe Antiepileptic Drugs Revenue (Million USD) Growth Rate (2015-2026) Figure 17. Europe Antiepileptic Drugs Sales (Million USD) Growth Rate (2015-2026) Figure 18. China Antiepileptic Drugs Revenue (Million USD) Growth Rate (2015-2026) Figure 19. China Antiepileptic Drugs Sales (Million USD) and Growth Rate (2015-2026) Figure 20. Japan Antiepileptic Drugs Revenue (Million USD) Growth Rate (2015-2026) Figure 21. Japan Antiepileptic Drugs Sales (Million USD) Growth Rate (2015-2026) Figure 22. Southeast Asia Antiepileptic Drugs Revenue (Million USD) Growth Rate (2015-2026) Figure 23. Southeast Asia Antiepileptic Drugs Sales (Million USD) Growth Rate (2015-2026) Figure 24. India Antiepileptic Drugs Revenue (Million USD) Growth Rate (2015-2026) Figure 25. India Antiepileptic Drugs Sales (Million USD) Growth Rate (2015-2026) Figure 26. Global 5 Largest Antiepileptic Drugs Players Market Share by Revenue in Antiepileptic Drugs 2015 & 2019 Figure 27. Antiepileptic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 28. Global Antiepileptic Drugs Revenue Share by Type (2015-2020) Figure 29. Global Antiepileptic Drugs Revenue Growth Rate by Type in 2015 & 2019 Figure 30. Global Antiepileptic Drugs Revenue Share by Application (2015-2020) Figure 31. Global Antiepileptic Drugs Revenue Growth Rate by Application in 2015 & 2019 Figure 32. United States Antiepileptic Drugs Sales Market Share by Type in 2019 Figure 33. United States Antiepileptic Drugs Sales Market Share by Type in 2019 Figure 34. Europe Antiepileptic Drugs Sales Market Share by Company in 2019 Figure 35. Europe Antiepileptic Drugs Sales Market Share by Type in 2019 Figure 36. Europe Antiepileptic Drugs Sales Market Share by Application in 2019 Figure 37. China Antiepileptic Drugs Sales Market Share by Company in 2019 Figure 38. China Antiepileptic Drugs Sales Market Share by Type in 2019 Figure 39. China Antiepileptic Drugs Sales Market Share by Application in 2019 Figure 40. Japan Antiepileptic Drugs Sales Market Share by Company in 2019 Figure 41. Japan Antiepileptic Drugs Sales Market Share by Type in 2019 Figure 42. Japan Antiepileptic Drugs Sales Market Share by Application in 2019 Figure 43. Southeast Asia Antiepileptic Drugs Sales Market Share by Company in 2019 Figure 44. Southeast Asia Antiepileptic Drugs Sales Market Share by Type in 2019 Figure 45. Southeast Asia Antiepileptic Drugs Sales Market Share by Application in 2019 Figure 46. India Antiepileptic Drugs Sales Market Share by Company in 2019 Figure 47. India Antiepileptic Drugs Sales Market Share by Type in 2019 Figure 48. India Antiepileptic Drugs Sales Market Share by Application in 2019 Figure 49. Key Raw Materials Price Trend Figure 50. Manufacturing Cost Structure of Antiepileptic Drugs Figure 51. Manufacturing Process Analysis of Antiepileptic Drugs Figure 52. Antiepileptic Drugs Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Porter's Five Forces Analysis Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

GlaxoSmithKline Johnson & Johnson Sanofi Pfizer Novartis Abbott Sunovion Cephalon (Teva)